Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML. - Smith SM; Zhang S; Sundaram V; Roth M; Andolina JR; Schapira L; Sakamoto KM; Kolb EA; Hijiya N; Chaudhury S (Pediatric hematology and oncology, 2022)